Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_assertion type Assertion NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_head.
- NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_assertion description "[In addition, we found ATOH1 expression in 9 (16%) out of 56 analyzed adenocarcinomas and these tumors showed neuroendocrine features as shown by dopa decarboxylase mRNA expression and immunostaining for neuroendocrine markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_provenance.
- NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_assertion evidence source_evidence_literature NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_provenance.
- NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_assertion SIO_000772 17549667 NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_provenance.
- NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_assertion wasDerivedFrom befree-20140225 NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_provenance.
- NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_assertion wasGeneratedBy ECO_0000203 NP731057.RADC3FGviS_3cEgz-9WgXDtDL0eAtN4LPuG3CNwihFDlQ130_provenance.